Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Julie Quartier"'
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1278 (2023)
The aim of this study was to investigate whether subtle differences in molecular properties affected polymeric micelle characteristics and their ability to deliver poorly water-soluble drugs into the skin. D-α-tocopherol-polyethylene glycol 1000 was
Externí odkaz:
https://doaj.org/article/38fe936befc0493fb034c74dbe7c5fc7
Publikováno v:
Pharmaceutics, Vol 11, Iss 9, p 484 (2019)
A draft guideline from the European Medicines Agency (EMA) highlights the need for methods to assess the quality/equivalence of topical drug formulations. The “cutaneous biodistribution method”, which provides insight into a drug’s spatial dist
Externí odkaz:
https://doaj.org/article/db7d364fcf1e4b2cb94f03ed59757483
Autor:
Younes Boulaguiem, Julie Quartier, Maria Lapteva, Yogeshvar N Kalia, Maria-Pia Victoria-Feser, Stéphane Guerrier, Dominique-Laurent Couturier
Average (bio)equivalence tests are used to assess if a parameter, like the mean difference in treatment response between two conditions for example, lies within a given equivalence interval, hence allowing to conclude that the conditions have ‘equi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a10e9b691f5863e0fbc2f060038112cc
https://doi.org/10.1101/2023.03.11.532179
https://doi.org/10.1101/2023.03.11.532179
Publikováno v:
International journal of pharmaceutics. 604
Facial angiofibromas are benign tumors characteristic of tuberous sclerosis complex. The disease involves the mTOR pathway and the cutaneous manifestation responds to topical treatment with sirolimus (SIR). However, there are no approved topical SIR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::350141619cd9f53a546cfab05ece6b59
https://pubmed.ncbi.nlm.nih.gov/34048926
https://pubmed.ncbi.nlm.nih.gov/34048926
Publikováno v:
International Journal of Pharmaceutics. 607:120967
The cutaneous biodistribution method (CBM) yields a high-resolution quantitative profile of drug deposition as a function of skin depth. However, it provides limited details about drug spatial distribution or penetration pathways. Mass spectrometry i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6df53ed511a82450c66427e2baf59b4b
https://doi.org/10.1016/j.ijpharm.2021.120967
https://doi.org/10.1016/j.ijpharm.2021.120967
Publikováno v:
Pharmaceutics
Volume 11
Issue 9
Pharmaceutics, Vol. 11, No 9 (2019)
Pharmaceutics, Vol 11, Iss 9, p 484 (2019)
Volume 11
Issue 9
Pharmaceutics, Vol. 11, No 9 (2019)
Pharmaceutics, Vol 11, Iss 9, p 484 (2019)
A draft guideline from the European Medicines Agency (EMA) highlights the need for methods to assess the quality/equivalence of topical drug formulations. The &ldquo
cutaneous biodistribution method&rdquo
which provides insight into a drug&
cutaneous biodistribution method&rdquo
which provides insight into a drug&
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a3d685286c1d7de27233e6bad12179